Ligne de temps

Maryline Bourgine
Ingénieur(e) de Recherche
07 sept. 2023
publication

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Lire plus
18 avr. 2023
publication

Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication.

Lire plus
01 janv. 2023
publication

Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.

Lire plus
21 déc. 2022
publication

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

Lire plus
27 avr. 2022
publication

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Lire plus
16 déc. 2021
publication

A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.

Lire plus
07 déc. 2021
publication

Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.

Lire plus
29 juil. 2021
team

Laboratoire Commun Pasteur – TheraVectys

Lire plus
18 avr. 2021
project

Humoral immune response & immunotherapy in HBV infection

Lire plus
16 déc. 2020
publication

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.

Lire plus
24 juin 2020
publication

Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.

Lire plus
23 juil. 2015
publication

Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes

Lire plus
16 déc. 2014
publication

Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?

Lire plus
26 nov. 2014
publication

TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

Lire plus
19 mars 2014
publication

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection

Lire plus
26 déc. 2013
publication

Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection

Lire plus